Digital Labeling Readiness 2026: Preparing For The Next Generation Of Electronic Product Information (ePI) And Global Pharmaceutical Labeling

How Digital Labeling, Structured Content, ePI, CCDS Governance, and Regulatory Intelligence Are Transforming Pharmaceutical Product Information Management

Digital labeling enables pharmaceutical companies to create, manage, and distribute approved product information using structured electronic content. As global regulators advance Electronic Product Information (ePI), organizations should strengthen structured content management, Company Core Data Sheet (CCDS) governance, digital workflows, and regulatory intelligence to improve compliance, accelerate labeling updates, and support future digital healthcare ecosystems.

Why Digital Labeling Is Becoming a Strategic Priority

Pharmaceutical labeling evolves from paper-based documents to structured digital content. While printed package inserts remain mandatory in many markets, regulators increasingly support Electronic Product Information (ePI) to improve accessibility, consistency, and lifecycle management.

Healthcare professionals and patients expect accurate, up-to-date digital product information, while regulators seek faster implementation of approved safety updates.

Without a digital labeling strategy, organizations may face:

• Delayed labeling updates 
• Inconsistent global product information 
• Manual review and document management 
• Higher operational costs 
• Labeling discrepancies 
• Limited content reuse 
• Inefficient change management 
• Reduced inspection readiness 

Digital labeling is now a strategic capability that improves compliance, operational efficiency, and global consistency.

Executive Overview

Digital labeling is transforming Regulatory Affairs by enabling structured management of approved product information throughout its lifecycle.

A future-ready program should be:

• Regulatory complaint 
• Patient-centric 
• Digitally enabled 
• Structured and standardized 
• Globally aligned 
• Lifecycle managed 
• Inspection ready 
• Scalable 
• Governed through strong CCDS management 
• Supported by regulatory intelligence 

Organizations adopting these capabilities improve efficiency while maintaining compliance across markets.

From Paper-Based Labeling to Digital Product Information

Traditional labeling depends on printed package inserts, prescribing information, carton text, and patient leaflets. Every approved safety update or manufacturing change often requires revisions across multiple markets.

Digital labeling manages approved information as structured electronic content, enabling faster updates and easier distribution.

Key Benefits

• Faster implementation of approved changes 
• Better accessibility 
• Improved searchability 
• Reduced dependence on paper 
• Integration with healthcare systems 
• Greater global consistency 
• Efficient lifecycle management 
• Better multilingual support 

What Is Digital Labeling Readiness?

Digital labeling readiness is an organization's ability to create, manage, govern, and distribute structured electronic product information while remaining compliant with global regulations.

Core capabilities include:

• Electronic Product Information (ePI) 
• Structured content management 
• CCDS governance 
• Labeling lifecycle management 
• Regulatory intelligence 
• Digital approval workflows 
• Content reuse 
• Change control 
• Global labeling harmonization 
• Data standardization 

Traditional Labeling vs. Digital Labeling

Key Drivers Accelerating Digital Labeling

1. Regulatory Modernization

Health authorities are increasingly supporting Electronic Product Information (ePI), enabling faster implementation of approved labeling updates.

2. Global Harmonization

Structured digital content improves consistency across markets, simplifies submissions, and reduces duplication.

3. Faster Safety Communication

Digital labeling allows healthcare professionals and patients to access approved safety updates more quickly.

4. Expansion of Digital Health

Structured product information supports integration with:

• Electronic Health Records (EHRs) 
• Clinical Decision Support Systems (CDSS) 
• Mobile health applications 
• Telemedicine 
• Digital patient engagement tools 

5. Sustainability

Digital labeling supports ESG initiatives by:

• Reducing paper consumption 
• Lowering printing needs 
• Improving document lifecycle efficiency 
• Supporting environmentally responsible operations 

Key Drivers of Digital Labeling Transformation

Why Structured Content Is the Foundation

Many companies still manage labeling through Word documents, PDFs, and spreadsheets, creating duplication and inconsistency.

Structured content organizes approved information into reusable components that can be centrally updated and reused across products and markets.

Benefits

• Content reuse 
• Better version control 
• Reduced duplication 
• Faster updates 
• Global consistency 
• Multilingual support 
• Automated publishing 

Benefits of Structured Content Management

Building a Digital-First Labeling Strategy

Digital labeling should be treated as a long-term business transformation.

Successful strategies include:

• Single source of truth 
• Strong CCDS governance 
• Structured content models 
• Digital approval workflows 
• Cross-functional collaboration 
• Regulatory intelligence 
• Lifecycle governance 
• Inspection-ready documentation 

Assessing Digital Labeling Readiness

1. Content Structure

Evaluate whether:

• Content is standardized 
• Information is reusable 
• Duplication is minimized 
• Content is centrally managed 
• Terminology is consistent 

2. CCDS Governance

Review:

• CCDS ownership 
• Approval workflows 
• Version control 
• Change management 
• Cross-functional review 
• Global responsibilities 

3. Technology Infrastructure

Assess support for:

• Structured content 
• ePI 
• Digital workflows 
• Regulatory document management 
• RIM integration 
• Cloud collaboration 
• Audit trails 
• Electronic records 

4. Regulatory Compliance

Review:

• Labeling reviews 
• Submission workflows 
• Change management 
• Inspection readiness 
• Health authority communication 
• Regulatory intelligence 

5. Global Labeling Strategy

Include:

• Centralized CCDS 
• Harmonized policies 
• Regional adaptation 
• Standard timelines 
• Governance committees 

Digital Labeling Readiness Assessment

Best Practices

Establish a Single Source of Truth

Improve:

• Consistency 
• Traceability 
• Version control 
• Global updates 

Strengthen CCDS Governance

Focus on:

• Regular reviews 
• Scientific consistency 
• Approval workflows 
• Version management 
• Market impact assessments 

Implement Structured Content

Enable:

• Content reuse 
• Automated publishing 
• Faster translations 
• Efficient submissions 
• Global consistency 

Promote Cross-Functional Collaboration

Involve:

• Regulatory Affairs 
• Medical Affairs 
• Pharmacovigilance 
• Quality Assurance 
• IT 
• Manufacturing 
• Supply Chain 
• Commercial teams 

Strengthening Regulatory Intelligence

Monitor:

• ePI initiatives 
• Regional guidance 
• Digital health regulations 
• Harmonization efforts 
• Data standards 
• Consultation papers 

Common Challenges

Organizations commonly face:

• Legacy systems 
• Fragmented processes 
• Inconsistent global content 
• Limited structured content 
• Regional differences 
• Resource constraints 
• Resistance to change 
• Data standardization issues 
• Multiple content owners 
• Complex approval workflows 

Common Mistakes

Avoid:

• Delaying digital transformation
• Managing content in multiple systems 
• Weak change control 
• Limited cross-functional engagement 
• Ignoring future regulatory trends 

Digital Labeling Implementation Roadmap

Future Trends

Emerging developments include:

• Electronic Product Information (ePI) 
• AI-assisted labeling 
• XML-based structured content 
• Digital first submissions 
• Cloud labeling platforms 
• Automated publishing 
• Global interoperability 
• EHR integration 
• QR code-enabled information 
• Patient-centric communication 
• Multilingual delivery 
• Enhanced cybersecurity 

Business Benefits

Frequently Asked Questions

1. What is digital labeling?

Structured electronic management and distribution of pharmaceutical product information.

2. What is ePI?

Electronic Product Information is a structured digital format for approved medicinal product information.

3. Why is digital labeling important?

It improves compliance, efficiency, accessibility, and lifecycle management.

4. What is CCDS?

The Company Core Data Sheet serves as the global reference for consistent product information.

5. Will digital labeling replace printed inserts?

Not entirely. Many regulators still require printed labeling while adopting hybrid approaches.

6. What is structured content management?

Managing reusable content components to improve consistency, traceability, and version control.

7. How can companies prepare?

• Strengthening CCDS governance 
• Standardized content 
• Implement structured content 
• Modernized workflows 
• Monitor regulations 
• Encourage collaboration 

8. What are the biggest challenges?

• Legacy systems 
• Fragmented repositories 
• Regional differences 
• Weak governance 
• Limited structured content 
• Change management 

9. How does digital labeling improve compliance?

It enhances consistency, audit trails, lifecycle management, submissions, and approved labeling updates.

10. How can Maven Regulatory Solutions help?

Maven supports:

• Digital labeling strategy 
• ePI readiness 
• CCDS governance 
• Structured content management 
• Global labeling lifecycle management 
• Regulatory intelligence 
• Gap assessments 
• Regulatory documentation 
• Process optimization 
• Global labeling harmonization 

Conclusion

Digital labeling is becoming a core element of pharmaceutical Regulatory Affairs. As regulators advance Electronic Product Information (ePI) and structured content standards, organizations should move from document-centric processes to digital-first labeling models.

Strengthening structured content, CCDS governance, regulatory intelligence, lifecycle management, and digital workflows improve compliance, accelerate approved labeling updates, enhance global consistency, and prepare organizations for the future of digital healthcare.

Why Choose Maven Regulatory Solutions?

Maven Regulatory Solutions helps pharmaceutical companies modernize labeling through digital labeling readiness assessments, structured content implementation, CCDS governance, regulatory intelligence, and global labeling lifecycle management. Our compliance-focused approach enables organizations to build scalable, efficient, and future-ready labeling programs while maintaining global regulatory compliance.